| 21 |
Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells
|
관리자 |
작성일21.01.13 |
조회592 |
| 20 |
Tristetraprolin posttranscriptionally downregulates PFKFB3 in cancer cells
|
관리자 |
작성일21.01.13 |
조회531 |
| 19 |
Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cells
|
관리자 |
작성일21.01.13 |
조회529 |
| 18 |
Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells
|
관리자 |
작성일21.01.13 |
조회521 |
| 17 |
Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells
|
관리자 |
작성일21.01.13 |
조회510 |
| 16 |
Tristetraprolin down-regulates IL-23 expression in colon cancer cells
|
관리자 |
작성일21.01.13 |
조회521 |
| 15 |
Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells
|
관리자 |
작성일21.01.13 |
조회536 |
| 14 |
Tristetraprolin suppresses AHRR expression through mRNA destabilization
|
관리자 |
작성일21.01.13 |
조회548 |
| 13 |
Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells
|
관리자 |
작성일21.01.13 |
조회614 |
| 12 |
Ectopic over-expression of tristetraprolin in human cancer cells promotes biogenesis of let-7 by down-regulation of Lin28
|
관리자 |
작성일21.01.13 |
조회622 |